These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 5159520)

  • 1. The effect of microencapsulation with ethyl cellulose upon the disintegration in vivo and the dissolution of iron tablets.
    Dahlström H; Eriksson S
    Acta Pharm Suec; 1971 Nov; 8(5):505-8. PubMed ID: 5159520
    [No Abstract]   [Full Text] [Related]  

  • 2. [The solubility kinetics of enteric-resistant tablets using riboflavin test tablets. 6. Pharmaceutic-technologic and analytic studies on gastric juice-resistant dosage forms].
    Thoma K; Oschmann R
    Pharmazie; 1991 May; 46(5):331-6. PubMed ID: 1896478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of film formers and plasticizers on the stability of resistance and disintegration behavior. 4. Pharmaceutical-technological and analytical studies of gastric juice-resistant commercial preparations].
    Thoma K; Heckenmüller H
    Pharmazie; 1987 Dec; 42(12):837-41. PubMed ID: 3444846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An investigation of the disintegration of tablets in biorelevant media.
    Anwar S; Fell JT; Dickinson PA
    Int J Pharm; 2005 Feb; 290(1-2):121-7. PubMed ID: 15664137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Tests on the disintegration of coated enterosoluble tablets. Influence of the composition of testing fluids on disintegration time in an artificial intestinal milieu of tablets coated with cellulose acetate phthalate].
    Delporte JP
    Farmaco Prat; 1975 Mar; 30(3):111-39. PubMed ID: 1204820
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of acid protective coating on absorption of erythromycin at oral administration].
    Koroleva VG; Belozerova OP; Vasil'ev VK; Stepnaia VE
    Antibiotiki; 1969 Dec; 14(12):1084-8. PubMed ID: 5371175
    [No Abstract]   [Full Text] [Related]  

  • 7. [Properties of tetracycline hydrochloride tablets and their bioavailability].
    Zak AF; Batuashvili TA; Loseva GI; Shatrova VM; Ermolova OB
    Antibiotiki; 1980 Mar; 25(3):179-84. PubMed ID: 7362222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The permeability of enteric coatings and the dissolution rates of coated tablets.
    Porter SC; Ridgway K
    J Pharm Pharmacol; 1982 Jan; 34(1):5-8. PubMed ID: 6121034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Resistance and disintegration behavior of gastric juice-resistant drug products. 3. Pharmaceutical-technological and analytical studies of gastric juice-resistant commercial preparations].
    Thoma K; Heckenmüller H; Oschmann R
    Pharmazie; 1987 Dec; 42(12):832-6. PubMed ID: 3444845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absorption of acetylsalicylic acid from enteric-coated tablets in relation to gastric emptying and in-vivo disintegration.
    Bogentoft C; Alpsten M; Ekenved G
    J Pharm Pharmacol; 1984 May; 36(5):350-1. PubMed ID: 6145780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disintegration of coated tablets -- unit-to-unit variation.
    Sandell E; Mellström G
    Acta Pharm Suec; 1975; 12(3):293-6. PubMed ID: 1163249
    [No Abstract]   [Full Text] [Related]  

  • 12. [The influence of temperature on disintegration and dissolution time of tablets with a cellulose component as a binder (author's transl)].
    Delonca H; Joachim J; Mattha A
    J Pharm Belg; 1978; 33(3):171-8. PubMed ID: 682103
    [No Abstract]   [Full Text] [Related]  

  • 13. Gastrointestinal transit and disintegration of enteric coated magnetic tablets assessed by ac biosusceptometry.
    Corá LA; Romeiro FG; Américo MF; Oliveira RB; Baffa O; Stelzer M; Miranda JR
    Eur J Pharm Sci; 2006 Jan; 27(1):1-8. PubMed ID: 16188432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The effect of the formulation of enterosoluble preparations on the physiologic dispensation of the active principle. Part 2: Effect of the elevation of disintegration time of coated tablets by augmentation of dentistry of coating on absorption characteristics of acetylsalicylic acid].
    Delporte JP; Jaminet F
    J Pharm Belg; 1976; 31(1):38-50. PubMed ID: 1255403
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of formulation of enterosoluable preparations on the physiologic availability of the active principle. 1: Effect on the rate of liberation of acetylsalicylic acid from enteric tablets on absorption characteristics in vivo].
    Delporte JP; Jaminet F
    J Pharm Belg; 1975; 30(2):99-113. PubMed ID: 1206458
    [No Abstract]   [Full Text] [Related]  

  • 16. [The relationship between the viscosity of the gastric juice and tablet disintegration].
    Hüttenrauch R; Zange D; Jacob J
    Pharmazie; 1973; 28(11):769-72. PubMed ID: 4791266
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of various factors on in vitro output velocity from delayed-action tablets 1. Tetracycline delayed-action tablets].
    Tomassini L; Naplatanova D
    Pharmazie; 1973 Jul; 28(7):447-9. PubMed ID: 4767491
    [No Abstract]   [Full Text] [Related]  

  • 18. Prediction of in vivo bioavailability of six brands of ciprofloxacin film coated tablets using the concept dissolution efficiency (DE).
    Ofoefule SI; Udeogaranya PO; Okonta JM
    Boll Chim Farm; 2001; 140(3):187-91. PubMed ID: 11486612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug release from tablets containing cellulose acetate phthalate as an additive or enteric-coating material.
    Lin SY; Kawashima Y
    Pharm Res; 1987 Feb; 4(1):70-4. PubMed ID: 3508533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the accuracy of different types of dissolution rate methods.
    Bolhuis GK; Lerk CF; Zuurman K
    Pharm Weekbl; 1973 Jan; 108(3):49-53. PubMed ID: 4699088
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.